Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Days after Pfizer asked U.S. regulators to authorize another booster for older adults, Moderna has followed with a similar request for all adults, arguing approval would “provide flexibility” to public health officials and doctors